Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Oct 8;87(4):538-44.
doi: 10.1016/j.ajhg.2010.09.007.

Mutations disrupting selenocysteine formation cause progressive cerebello-cerebral atrophy

Orly Agamy  1 , Bruria Ben Zeev, Dorit Lev, Barak Marcus, Dina Fine, Dan Su, Ginat Narkis, Rivka Ofir, Chen Hoffmann, Esther Leshinsky-Silver, Hagit Flusser, Sara Sivan, Dieter Söll, Tally Lerman-Sagie, Ohad S Birk
Affiliations

Mutations disrupting selenocysteine formation cause progressive cerebello-cerebral atrophy

Orly Agamy et al. Am J Hum Genet. .

Abstract

The essential micronutrient selenium is found in proteins as selenocysteine (Sec), the only genetically encoded amino acid whose biosynthesis occurs on its cognate tRNA in humans. In the final step of selenocysteine formation, the essential enzyme SepSecS catalyzes the conversion of Sep-tRNA to Sec-tRNA. We demonstrate that SepSecS mutations cause autosomal-recessive progressive cerebellocerebral atrophy (PCCA) in Jews of Iraqi and Moroccan ancestry. Both founder mutations, common in these two populations, disrupt the sole route to the biosynthesis of the 21st amino acid, Sec, and thus to the generation of selenoproteins in humans.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Sequential MRI Studies in PCCA Images are of individual 4 of family A (Figure 2). (A) Age 8 months: a T1 coronal image at the level of the occipital lobes demonstrates a normal-looking brain. (B) Age 18 months: a T1 sagital image showing vermian atrophy with mild cerebral atrophy. (C) Age 3 years: a coronal image at the level of the occipital lobes demonstrates severe cerebellar and cerebral atrophy.
Figure 2
Figure 2
Genetic Mapping of the Disease-Associated Locus Haplotypes of all four families on chromosome 4p15.2 are shown. The disease-associated haplotype is boxed. Additional microsatellite markers were used for fine mapping the candidate region identified by the genome-wide scan with the 10K SNP arrays. Families A and B are of Iraqi origin. Families C and D are of Iraqi and Moroccan origin. The minimum disease-associated haplotype lies between markers D4S425 and D4S391 for the “Iraqi” haplotype and between markers D4S1551 and rs2048506 for the “Moroccan” haplotype. Gray shading indicates the SepSecS position within the haplotype.
Figure 3
Figure 3
SepSecS Mutations in PCCA Families (A–C) The c.1001A>G SepSecS mutation in exon 8. Sequence analysis is shown for an affected individual (A), a carrier (B), and an unaffected individual (C) in families A and B. (D and E) The c.715G>A mutation in exon 6. Sequence analysis is shown for a carrier (D) and unaffected individuals (E) in families C and D. Affected individuals in families C and D were compound heterozygous for the two mutations. The arrows indicate the positions of the mutations.
Figure 4
Figure 4
Alignment of the Mutated Sequence Regions in Some Eukaryotic and Archaeal SepSecS Proteins
Figure 5
Figure 5
Functional Studies of the SepSecS Mutations In vivo assays of human SepSecS mutants. Formation of Sec-tRNASec in vivo is assayed by the ability of the wild-type human SepSecS and the mutant variants p.Lys284Thr, p,Ala239Thr, and p.Tyr334Cys to restore the benzyl-viologen-reducing activity of the selenoprotein FDHH in the E. coli ΔselA deletion strain. The Methanocaldococcus jannaschii PSTK is cotransformed to generate the Sep-tRNASec intermediate. K284T is a previously described inactive SepSecS mutant.
Figure 6
Figure 6
Structure of Selenocysteine and Its Route of Biosynthesis Seryl-tRNA synthetase attaches serine to tRNASec. (Top) Bacteria use selenocysteine synthase (SelA) to convert Ser-tRNASec directly to Sec-tRNASec. (Bottom) Eukaryotes and archaea employ a two-step conversion; a kinase (PSTK) provides the phosphorylated intermediate Sep-tRNASec, the required substrate of SepSecS (see text).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Ben-Zeev B., Hoffman C., Lev D., Watemberg N., Malinger G., Brand N., Lerman-Sagie T. Progressive cerebellocerebral atrophy: a new syndrome with microcephaly, mental retardation, and spastic quadriplegia. J. Med. Genet. 2003;40:e96. - PMC - PubMed
    1. Thiele H., Nürnberg P. HaploPainter: a tool for drawing pedigrees with complex haplotypes. Bioinformatics. 2005;21:1730–1732. - PubMed
    1. Gefen A., Cohen R., Birk O.S. Syndrome to gene (S2G): In-silico identification of candidate genes for human diseases. Hum. Mutat. 2010;31:229–236. - PubMed
    1. Budde B.S., Namavar Y., Barth P.G., Poll-The B.T., Nürnberg G., Becker C., van Ruissen F., Weterman M.A., Fluiter K., te Beek E.T. tRNA splicing endonuclease mutations cause pontocerebellar hypoplasia. Nat. Genet. 2008;40:1113–1118. - PubMed
    1. Yuan J., Palioura S., Salazar J.C., Su D., O'Donoghue P., Hohn M.J., Cardoso A.M., Whitman W.B., Söll D. RNA-dependent conversion of phosphoserine forms selenocysteine in eukaryotes and archaea. Proc. Natl. Acad. Sci. USA. 2006;103:18923–18927. - PMC - PubMed

Publication types

MeSH terms

Substances